Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 128 entries
Sorted by: Best Match Show Resources per page
High-Performance Plasma-Enabled Biorefining of Microalgae to Value-Added Products.

ChemSusChem

Zhou R, Zhou R, Zhang X, Fang Z, Wang X, Speight R, Wang H, Doherty W, Cullen PJ, Ostrikov KK, Bazaka K.
PMID: 31441585
ChemSusChem. 2019 Nov 22;12(22):4976-4985. doi: 10.1002/cssc.201901772. Epub 2019 Oct 23.

Conversion of renewable biomass by time- and energy-efficient techniques remains an important challenge. Herein, plasma catalytic liquefaction (PCL) is employed to achieve rapid liquefaction of microalgae under mild conditions. The choice of the catalyst affects both the liquefaction efficiency...

Cite
Zhou R, Zhou R, Zhang X, et al. High-Performance Plasma-Enabled Biorefining of Microalgae to Value-Added Products. ChemSusChem. 2019;12(22):4976-4985doi: 10.1002/cssc.201901772.
Zhou, R., Zhou, R., Zhang, X., Fang, Z., Wang, X., Speight, R., Wang, H., Doherty, W., Cullen, P. J., Ostrikov, K. K., & Bazaka, K. (2019). High-Performance Plasma-Enabled Biorefining of Microalgae to Value-Added Products. ChemSusChem, 12(22), 4976-4985. https://doi.org/10.1002/cssc.201901772
Zhou, Renwu, et al. "High-Performance Plasma-Enabled Biorefining of Microalgae to Value-Added Products." ChemSusChem vol. 12,22 (2019): 4976-4985. doi: https://doi.org/10.1002/cssc.201901772
Zhou R, Zhou R, Zhang X, Fang Z, Wang X, Speight R, Wang H, Doherty W, Cullen PJ, Ostrikov KK, Bazaka K. High-Performance Plasma-Enabled Biorefining of Microalgae to Value-Added Products. ChemSusChem. 2019 Nov 22;12(22):4976-4985. doi: 10.1002/cssc.201901772. Epub 2019 Oct 23. PMID: 31441585.
Copy Download .nbib Format: NLM
Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes: A systematic review update and qualitative synthesis applying the Theoretical Domains Framework.

Diabetic medicine : a journal of the British Diabetic Association

Lake AJ, Neven ACH, Williams A, O'Reilly SL, Hendrieckx C, Morrison M, Dunbar J, Teede H, Boyle JA, Speight J.
PMID: 34953147
Diabet Med. 2021 Dec 25;e14772. doi: 10.1111/dme.14772. Epub 2021 Dec 25.

AIMS: Women with prior gestational diabetes have nearly 10 times the risk of developing type 2 diabetes. Postpartum screening for type 2 diabetes is recommended for early diagnosis and management, yet uptake is low. This work updates a previous...

Cite
Lake AJ, Neven ACH, Williams A, et al. Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes: A systematic review update and qualitative synthesis applying the Theoretical Domains Framework. Diabet Med. 2021;e14772doi: 10.1111/dme.14772.
Lake, A. J., Neven, A. C. H., Williams, A., O'Reilly, S. L., Hendrieckx, C., Morrison, M., Dunbar, J., Teede, H., Boyle, J. A., Speight, J. (2021). Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes: A systematic review update and qualitative synthesis applying the Theoretical Domains Framework. Diabetic medicine : a journal of the British Diabetic Association, e14772. https://doi.org/10.1111/dme.14772
Lake, Amelia J, et al. "Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes: A systematic review update and qualitative synthesis applying the Theoretical Domains Framework." Diabetic medicine : a journal of the British Diabetic Association vol. (2021): e14772. doi: https://doi.org/10.1111/dme.14772
Lake AJ, Neven ACH, Williams A, O'Reilly SL, Hendrieckx C, Morrison M, Dunbar J, Teede H, Boyle JA, Speight J. Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes: A systematic review update and qualitative synthesis applying the Theoretical Domains Framework. Diabet Med. 2021 Dec 25;e14772. doi: 10.1111/dme.14772. Epub 2021 Dec 25. PMID: 34953147.
Copy Download .nbib Format: NLM
TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS).

Journal of wildlife diseases

Buchanan C, Woolford L, Stephenson T, Hoebergen M, Kovac JH, Breed WG, Speight N.
PMID: 34797903
J Wildl Dis. 2021 Nov 19; doi: 10.7589/JWD-D-21-00055. Epub 2021 Nov 19.

Testis asymmetry, in which the testes in an individual differ in size, has recently been reported in koalas (Phascolarctos cinereus) in the Mount Lofty Ranges population of South Australia. We describe the morphology and histology of both testes from...

Cite
Buchanan C, Woolford L, Stephenson T, et al. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). J Wildl Dis. 2021;doi: 10.7589/JWD-D-21-00055.
Buchanan, C., Woolford, L., Stephenson, T., Hoebergen, M., Kovac, J. H., Breed, W. G., & Speight, N. (2021). TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). Journal of wildlife diseases, . https://doi.org/10.7589/JWD-D-21-00055
Buchanan, Chloe, et al. "TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS)." Journal of wildlife diseases vol. (2021). doi: https://doi.org/10.7589/JWD-D-21-00055
Buchanan C, Woolford L, Stephenson T, Hoebergen M, Kovac JH, Breed WG, Speight N. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). J Wildl Dis. 2021 Nov 19; doi: 10.7589/JWD-D-21-00055. Epub 2021 Nov 19. PMID: 34797903.
Copy Download .nbib Format: NLM
TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS).

Journal of wildlife diseases

Buchanan C, Woolford L, Stephenson T, Hoebergen M, Kovac JH, Breed WG, Speight N.
PMID: 34797903
J Wildl Dis. 2022 Jan 01;58(1):158-167. doi: 10.7589/JWD-D-21-00055.

Testis asymmetry, in which the testes in an individual differ in size, has recently been reported in koalas (Phascolarctos cinereus) in the Mount Lofty Ranges population of South Australia. We describe the morphology and histology of both testes from...

Cite
Buchanan C, Woolford L, Stephenson T, et al. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). J Wildl Dis. 2022;58(1):158-167doi: 10.7589/JWD-D-21-00055.
Buchanan, C., Woolford, L., Stephenson, T., Hoebergen, M., Kovac, J. H., Breed, W. G., & Speight, N. (2022). TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). Journal of wildlife diseases, 58(1), 158-167. https://doi.org/10.7589/JWD-D-21-00055
Buchanan, Chloe, et al. "TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS)." Journal of wildlife diseases vol. 58,1 (2022): 158-167. doi: https://doi.org/10.7589/JWD-D-21-00055
Buchanan C, Woolford L, Stephenson T, Hoebergen M, Kovac JH, Breed WG, Speight N. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). J Wildl Dis. 2022 Jan 01;58(1):158-167. doi: 10.7589/JWD-D-21-00055. PMID: 34797903.
Copy Download .nbib Format: NLM
A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed.

Diabetologia

Speight J, Skinner TC, Huber JW, Lake AJ, Messina R, Mocan A, Nefs G, Newson L, Povey R, Vallis M, Willaing I.
PMID: 34778926
Diabetologia. 2022 Feb;65(2):406-408. doi: 10.1007/s00125-021-05615-z. Epub 2021 Nov 15.

No abstract available.

Cite
Speight J, Skinner TC, Huber JW, et al. A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed. Diabetologia. 2021;65(2):406-408doi: 10.1007/s00125-021-05615-z.
Speight, J., Skinner, T. C., Huber, J. W., Lake, A. J., Messina, R., Mocan, A., Nefs, G., Newson, L., Povey, R., Vallis, M., Willaing, I. (2022). A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed. Diabetologia, 65(2), 406-408. https://doi.org/10.1007/s00125-021-05615-z
Speight, Jane, et al. "A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed." Diabetologia vol. 65,2 (2022): 406-408. doi: https://doi.org/10.1007/s00125-021-05615-z
Speight J, Skinner TC, Huber JW, Lake AJ, Messina R, Mocan A, Nefs G, Newson L, Povey R, Vallis M, Willaing I. A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed. Diabetologia. 2022 Feb;65(2):406-408. doi: 10.1007/s00125-021-05615-z. Epub 2021 Nov 15. PMID: 34778926.
Copy Download .nbib Format: NLM
Life-Threatening Malnutrition in Very Severe ME/CFS.

Healthcare (Basel, Switzerland)

Baxter H, Speight N, Weir W.
PMID: 33919671
Healthcare (Basel). 2021 Apr 14;9(4). doi: 10.3390/healthcare9040459.

Very severe Myalgic Encephalomyelitis (ME), (also known as Chronic Fatigue Syndrome) can lead to problems with nutrition and hydration. The reasons can be an inability to swallow, severe gastrointestinal problems tolerating food or the patient being too debilitated to...

Cite
Baxter H, Speight N, Weir W. Life-Threatening Malnutrition in Very Severe ME/CFS. Healthcare (Basel). 2021;9(4)doi: 10.3390/healthcare9040459.
Baxter, H., Speight, N., & Weir, W. (2021). Life-Threatening Malnutrition in Very Severe ME/CFS. Healthcare (Basel, Switzerland), 9(4), . https://doi.org/10.3390/healthcare9040459
Baxter, Helen, et al. "Life-Threatening Malnutrition in Very Severe ME/CFS." Healthcare (Basel, Switzerland) vol. 9,4 (2021). doi: https://doi.org/10.3390/healthcare9040459
Baxter H, Speight N, Weir W. Life-Threatening Malnutrition in Very Severe ME/CFS. Healthcare (Basel). 2021 Apr 14;9(4). doi: 10.3390/healthcare9040459. PMID: 33919671; PMCID: PMC8070213.
Copy Download .nbib Format: NLM
Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer - Optimising the Patient Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))

Bird D, Speight R, Al-Qaisieh B, Henry AM.
PMID: 33992498
Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e422-e424. doi: 10.1016/j.clon.2021.04.014. Epub 2021 May 12.

No abstract available.

Cite
Bird D, Speight R, Al-Qaisieh B, et al. Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer - Optimising the Patient Experience. Clin Oncol (R Coll Radiol). 2021;33(10):e422-e424doi: 10.1016/j.clon.2021.04.014.
Bird, D., Speight, R., Al-Qaisieh, B., & Henry, A. M. (2021). Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer - Optimising the Patient Experience. Clinical oncology (Royal College of Radiologists (Great Britain)), 33(10), e422-e424. https://doi.org/10.1016/j.clon.2021.04.014
Bird, D, et al. "Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer - Optimising the Patient Experience." Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 33,10 (2021): e422-e424. doi: https://doi.org/10.1016/j.clon.2021.04.014
Bird D, Speight R, Al-Qaisieh B, Henry AM. Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer - Optimising the Patient Experience. Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e422-e424. doi: 10.1016/j.clon.2021.04.014. Epub 2021 May 12. PMID: 33992498.
Copy Download .nbib Format: NLM
High-Efficiency Biocatalytic Conversion of Thebaine to Codeine.

ACS omega

Li X, Krysiak-Baltyn K, Richards L, Jarrold A, Stevens GW, Bowser T, Speight RE, Gras SL.
PMID: 32363285
ACS Omega. 2020 Apr 03;5(16):9339-9347. doi: 10.1021/acsomega.0c00282. eCollection 2020 Apr 28.

An enzymatic biosynthesis approach is described for codeine, the most widely used medicinal opiate, providing a more environmentally sustainable alternative to current chemical conversion, with yields and productivity compatible with industrial production.

Cite
Li X, Krysiak-Baltyn K, Richards L, et al. High-Efficiency Biocatalytic Conversion of Thebaine to Codeine. ACS Omega. 2020;5(16):9339-9347doi: 10.1021/acsomega.0c00282.
Li, X., Krysiak-Baltyn, K., Richards, L., Jarrold, A., Stevens, G. W., Bowser, T., Speight, R. E., & Gras, S. L. (2020). High-Efficiency Biocatalytic Conversion of Thebaine to Codeine. ACS omega, 5(16), 9339-9347. https://doi.org/10.1021/acsomega.0c00282
Li, Xu, et al. "High-Efficiency Biocatalytic Conversion of Thebaine to Codeine." ACS omega vol. 5,16 (2020): 9339-9347. doi: https://doi.org/10.1021/acsomega.0c00282
Li X, Krysiak-Baltyn K, Richards L, Jarrold A, Stevens GW, Bowser T, Speight RE, Gras SL. High-Efficiency Biocatalytic Conversion of Thebaine to Codeine. ACS Omega. 2020 Apr 03;5(16):9339-9347. doi: 10.1021/acsomega.0c00282. eCollection 2020 Apr 28. PMID: 32363285; PMCID: PMC7191831.
Copy Download .nbib Format: NLM
Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record.

JMIR formative research

Kunstler BE, Furler J, Holmes-Truscott E, McLachlan H, Boyle D, Lo S, Speight J, O'Neal D, Audehm R, Kilov G, Manski-Nankervis JA.
PMID: 32876576
JMIR Form Res. 2020 Sep 02;4(9):e17785. doi: 10.2196/17785.

BACKGROUND: Managing type 2 diabetes (T2D) requires progressive lifestyle changes and, sometimes, pharmacological treatment intensification. General practitioners (GPs) are integral to this process but can find pharmacological treatment intensification challenging because of the complexity of continually emerging treatment options.OBJECTIVE:...

Cite
Kunstler BE, Furler J, Holmes-Truscott E, et al. Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record. JMIR Form Res. 2020;4(9):e17785doi: 10.2196/17785.
Kunstler, B. E., Furler, J., Holmes-Truscott, E., McLachlan, H., Boyle, D., Lo, S., Speight, J., O'Neal, D., Audehm, R., Kilov, G., & Manski-Nankervis, J. A. (2020). Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record. JMIR formative research, 4(9), e17785. https://doi.org/10.2196/17785
Kunstler, Breanne E, et al. "Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record." JMIR formative research vol. 4,9 (2020): e17785. doi: https://doi.org/10.2196/17785
Kunstler BE, Furler J, Holmes-Truscott E, McLachlan H, Boyle D, Lo S, Speight J, O'Neal D, Audehm R, Kilov G, Manski-Nankervis JA. Guiding Glucose Management Discussions Among Adults With Type 2 Diabetes in General Practice: Development and Pretesting of a Clinical Decision Support Tool Prototype Embedded in an Electronic Medical Record. JMIR Form Res. 2020 Sep 02;4(9):e17785. doi: 10.2196/17785. PMID: 32876576; PMCID: PMC7495264.
Copy Download .nbib Format: NLM
A Diverse View of Science to Catalyse Change.

Angewandte Chemie (International ed. in English)

Urbina-Blanco CA, Jilani SZ, Speight IR, Bojdys MJ, Friščić T, Stoddart JF, Nelson TL, Mack J, Robinson RAS, Waddell EA, Lutkenhaus JL, Godfrey M, Abboud MI, Aderinto SO, Aderohunmu D, Bibič L, Borges J, Dong VM, Ferrins L, Fung FM, John T, Lim FPL, Masters SL, Mambwe D, Thordarson P, Titirici MM, Tormet-González GD, Unterlass MM, Wadle A, Yam VW, Yang YW.
PMID: 33448562
Angew Chem Int Ed Engl. 2020 Oct 12;59(42):18306-18310. doi: 10.1002/anie.202009834. Epub 2020 Aug 17.

Valuing diversity leads to scientific excellence, the progress of science and most importantly, it is simply the right thing to do. We can value diversity not only in words, but also in actions.

Cite
Urbina-Blanco CA, Jilani SZ, Speight IR, et al. A Diverse View of Science to Catalyse Change. Angew Chem Int Ed Engl. 2020;59(42):18306-18310doi: 10.1002/anie.202009834.
Urbina-Blanco, C. A., Jilani, S. Z., Speight, I. R., Bojdys, M. J., Friščić, T., Stoddart, J. F., Nelson, T. L., Mack, J., Robinson, R. A. S., Waddell, E. A., Lutkenhaus, J. L., Godfrey, M., Abboud, M. I., Aderinto, S. O., Aderohunmu, D., Bibič, L., Borges, J., Dong, V. M., Ferrins, L., Fung, F. M., John, T., Lim, F. P. L., Masters, S. L., Mambwe, D., Thordarson, P., Titirici, M. M., Tormet-González, G. D., Unterlass, M. M., Wadle, A., Yam, V. W., & Yang, Y. W. (2020). A Diverse View of Science to Catalyse Change. Angewandte Chemie (International ed. in English), 59(42), 18306-18310. https://doi.org/10.1002/anie.202009834
Urbina-Blanco, César A, et al. "A Diverse View of Science to Catalyse Change." Angewandte Chemie (International ed. in English) vol. 59,42 (2020): 18306-18310. doi: https://doi.org/10.1002/anie.202009834
Urbina-Blanco CA, Jilani SZ, Speight IR, Bojdys MJ, Friščić T, Stoddart JF, Nelson TL, Mack J, Robinson RAS, Waddell EA, Lutkenhaus JL, Godfrey M, Abboud MI, Aderinto SO, Aderohunmu D, Bibič L, Borges J, Dong VM, Ferrins L, Fung FM, John T, Lim FPL, Masters SL, Mambwe D, Thordarson P, Titirici MM, Tormet-González GD, Unterlass MM, Wadle A, Yam VW, Yang YW. A Diverse View of Science to Catalyse Change. Angew Chem Int Ed Engl. 2020 Oct 12;59(42):18306-18310. doi: 10.1002/anie.202009834. Epub 2020 Aug 17. PMID: 33448562; PMCID: PMC7590070.
Copy Download .nbib Format: NLM
Does nocturnal hypoglycaemia really improve quality of life?.

Diabetologia

Søholm U, Broadley MM, Choudhary P, Zaremba N, Amiel SA, Speight J, Pouwer F.
PMID: 34014372
Diabetologia. 2021 Aug;64(8):1893-1894. doi: 10.1007/s00125-021-05475-7. Epub 2021 May 20.

No abstract available.

Cite
Søholm U, Broadley MM, Choudhary P, et al. Does nocturnal hypoglycaemia really improve quality of life?. Diabetologia. 2021;64(8):1893-1894doi: 10.1007/s00125-021-05475-7.
Søholm, U., Broadley, M. M., Choudhary, P., Zaremba, N., Amiel, S. A., Speight, J., & Pouwer, F. (2021). Does nocturnal hypoglycaemia really improve quality of life?. Diabetologia, 64(8), 1893-1894. https://doi.org/10.1007/s00125-021-05475-7
Søholm, Uffe, et al. "Does nocturnal hypoglycaemia really improve quality of life?." Diabetologia vol. 64,8 (2021): 1893-1894. doi: https://doi.org/10.1007/s00125-021-05475-7
Søholm U, Broadley MM, Choudhary P, Zaremba N, Amiel SA, Speight J, Pouwer F. Does nocturnal hypoglycaemia really improve quality of life?. Diabetologia. 2021 Aug;64(8):1893-1894. doi: 10.1007/s00125-021-05475-7. Epub 2021 May 20. PMID: 34014372.
Copy Download .nbib Format: NLM
'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association

Holmes-Truscott E, Schipp J, Dunning T, Furler J, Hagger V, Holloway EE, Manski-Nankervis JA, Shaw JE, Skinner T, Speight J.
PMID: 34465005
Diabet Med. 2022 Feb;39(2):e14681. doi: 10.1111/dme.14681. Epub 2021 Sep 04.

AIMS: This qualitative study aims to explore beliefs, attitudes and experiences of injectable glucagon-like-peptide-1 receptor agonists (GLP-1RAs) use and discontinuation, as well as attitudes to further injectable treatment intensification, among adults with type 2 diabetes (T2D).METHODS: Nineteen in-depth semi-structured...

Cite
Holmes-Truscott E, Schipp J, Dunning T, et al. 'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabet Med. 2021;39(2):e14681doi: 10.1111/dme.14681.
Holmes-Truscott, E., Schipp, J., Dunning, T., Furler, J., Hagger, V., Holloway, E. E., Manski-Nankervis, J. A., Shaw, J. E., Skinner, T., & Speight, J. (2022). 'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 39(2), e14681. https://doi.org/10.1111/dme.14681
Holmes-Truscott, Elizabeth, et al. "'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes." Diabetic medicine : a journal of the British Diabetic Association vol. 39,2 (2022): e14681. doi: https://doi.org/10.1111/dme.14681
Holmes-Truscott E, Schipp J, Dunning T, Furler J, Hagger V, Holloway EE, Manski-Nankervis JA, Shaw JE, Skinner T, Speight J. 'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabet Med. 2022 Feb;39(2):e14681. doi: 10.1111/dme.14681. Epub 2021 Sep 04. PMID: 34465005.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 128 entries